Innovative Tyres & Tubes Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 29, 2025, 9:08 pm

Quick Insight

Innovative Tyres & Tubes Ltd is currently trading at ₹107 with a market capitalization of ₹107 Cr. The company's Return on Capital Employed (ROCE) stands impressively high at 49.4%, indicating efficient utilization of capital to generate profits. However, the negative Operating Profit Margin (OPM) of -17% and Net Profit of -16 Cr are concerning, suggesting operational inefficiencies and profitability challenges. With Promoters holding a significant 94.55% stake, the company showcases strong promoter confidence and alignment with shareholder interests.

One key strength of the company lies in its robust ROCE, outperforming sector averages, which signifies effective capital deployment. Conversely, the high level of Borrowings at ₹43 Cr and negative Reserves of -26 Cr pose significant financial risks, impacting the company's solvency and financial stability. Moving forward, a reduction in borrowing levels through improved operational efficiency and profitability could enhance the company's financial health and long-term sustainability.

In conclusion, while Innovative Tyres & Tubes Ltd exhibits strengths in capital efficiency and promoter confidence, addressing operational inefficiencies and reducing debt levels are crucial for mitigating financial risks and improving overall performance. Investors should closely monitor the company's efforts to enhance profitability and strengthen its balance sheet to assess its long-term viability in the competitive Tyres & Tubes industry.

Competitors of Innovative Tyres & Tubes Ltd

All Competitor Stocks of Innovative Tyres & Tubes Ltd

Quarterly Result

Last Updated: August 9, 2025, 10:52 am

Below is a detailed analysis of the quarterly data for Innovative Tyres & Tubes Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Sep 2024) to 27.00 Cr., marking an increase of 7.00 Cr..
• For Expenses, as of Mar 2025, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.00 Cr. (Sep 2024) to 32.00 Cr., marking an increase of 6.00 Cr..
• For Operating Profit, as of Mar 2025, the value is -5.00 Cr.. The value appears strong and on an upward trend. It has increased from -7.00 Cr. (Sep 2024) to -5.00 Cr., marking an increase of 2.00 Cr..
• For OPM %, as of Mar 2025, the value is -17.00%. The value appears strong and on an upward trend. It has increased from -35.00% (Sep 2024) to -17.00%, marking an increase of 18.00%.
• For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Interest, as of Mar 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Sep 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 2.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -7.00 Cr.. The value appears strong and on an upward trend. It has increased from -9.00 Cr. (Sep 2024) to -7.00 Cr., marking an increase of 2.00 Cr..
• For Tax %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00%.
• For Net Profit, as of Mar 2025, the value is -7.00 Cr.. The value appears strong and on an upward trend. It has increased from -9.00 Cr. (Sep 2024) to -7.00 Cr., marking an increase of 2.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -7.07. The value appears strong and on an upward trend. It has increased from -8.94 (Sep 2024) to -7.07, marking an increase of 1.87.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 9, 2025, 10:52 am

Growth

Last Updated: September 5, 2025, 7:40 am

Balance Sheet

Last Updated: August 9, 2025, 10:52 am

Below is a detailed analysis of the balance sheet data for Innovative Tyres & Tubes Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Mar 2024) to 10.00 Cr., marking a decrease of 8.00 Cr..
• For Reserves, as of Mar 2025, the value is -26.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -18.00 Cr. (Mar 2024) to -26.00 Cr., marking a decline of 8.00 Cr..
• For Borrowings, as of Mar 2025, the value is 43.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 35.00 Cr. (Mar 2024) to 43.00 Cr., marking an increase of 8.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2024) to 29.00 Cr., marking an increase of 21.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 55.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 42.00 Cr. (Mar 2024) to 55.00 Cr., marking an increase of 13.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 32.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2024) to 32.00 Cr., marking a decrease of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 10.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 14.00 Cr., marking an increase of 8.00 Cr..
• For Total Assets, as of Mar 2025, the value is 55.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2024) to 55.00 Cr., marking an increase of 13.00 Cr..

However, the Borrowings (43.00 Cr.) are higher than the Reserves (-26.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Innovative Tyres & Tubes Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 19.17. This value is within the healthy range. It has increased from -29.42 (Mar 23) to 19.17, marking an increase of 48.59.
• For Diluted EPS (Rs.), as of Mar 24, the value is 19.17. This value is within the healthy range. It has increased from -29.42 (Mar 23) to 19.17, marking an increase of 48.59.
• For Cash EPS (Rs.), as of Mar 24, the value is 21.63. This value is within the healthy range. It has increased from -24.87 (Mar 23) to 21.63, marking an increase of 46.50.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -9.45. It has increased from -28.63 (Mar 23) to -9.45, marking an increase of 19.18.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -5.41. It has increased from -24.58 (Mar 23) to -5.41, marking an increase of 19.17.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 7.88. It has increased from 0.90 (Mar 23) to 7.88, marking an increase of 6.98.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 0.36. This value is below the healthy minimum of 2. It has increased from -29.53 (Mar 23) to 0.36, marking an increase of 29.89.
• For PBIT / Share (Rs.), as of Mar 24, the value is -2.10. This value is below the healthy minimum of 0. It has increased from -34.08 (Mar 23) to -2.10, marking an increase of 31.98.
• For PBT / Share (Rs.), as of Mar 24, the value is 19.16. This value is within the healthy range. It has increased from -34.13 (Mar 23) to 19.16, marking an increase of 53.29.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 19.17. This value is within the healthy range. It has increased from -29.42 (Mar 23) to 19.17, marking an increase of 48.59.
• For PBDIT Margin (%), as of Mar 24, the value is 4.57. This value is below the healthy minimum of 10. It has increased from -3,271.20 (Mar 23) to 4.57, marking an increase of 3,275.77.
• For PBIT Margin (%), as of Mar 24, the value is -26.63. This value is below the healthy minimum of 10. It has increased from -3,774.96 (Mar 23) to -26.63, marking an increase of 3,748.33.
• For PBT Margin (%), as of Mar 24, the value is 243.12. This value is within the healthy range. It has increased from -3,780.36 (Mar 23) to 243.12, marking an increase of 4,023.48.
• For Net Profit Margin (%), as of Mar 24, the value is 243.31. This value exceeds the healthy maximum of 10. It has increased from -3,258.83 (Mar 23) to 243.31, marking an increase of 3,502.14.
• For Return on Networth / Equity (%), as of Mar 24, the value is -202.81. This value is below the healthy minimum of 15. It has decreased from 0.00 (Mar 23) to -202.81, marking a decrease of 202.81.
• For Return on Capital Employeed (%), as of Mar 24, the value is -20.51. This value is below the healthy minimum of 10. It has decreased from 138.66 (Mar 23) to -20.51, marking a decrease of 159.17.
• For Return On Assets (%), as of Mar 24, the value is 81.88. This value is within the healthy range. It has increased from -146.90 (Mar 23) to 81.88, marking an increase of 228.78.
• For Long Term Debt / Equity (X), as of Mar 24, the value is -1.09. This value is below the healthy minimum of 0.2. It has decreased from 0.00 (Mar 23) to -1.09, marking a decrease of 1.09.
• For Total Debt / Equity (X), as of Mar 24, the value is -2.05. This value is within the healthy range. It has decreased from -0.73 (Mar 23) to -2.05, marking a decrease of 1.32.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.36. It has increased from 0.02 (Mar 23) to 0.36, marking an increase of 0.34.
• For Current Ratio (X), as of Mar 24, the value is 0.17. This value is below the healthy minimum of 1.5. It has increased from 0.02 (Mar 23) to 0.17, marking an increase of 0.15.
• For Quick Ratio (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 23) to 0.05, marking an increase of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 9.02. This value exceeds the healthy maximum of 8. It has increased from 0.78 (Mar 23) to 9.02, marking an increase of 8.24.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 30.73. This value is within the healthy range. It has increased from -605.90 (Mar 23) to 30.73, marking an increase of 636.63.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -177.64. This value is below the healthy minimum of 3. It has increased from -602.61 (Mar 23) to -177.64, marking an increase of 424.97.
• For Enterprise Value (Cr.), as of Mar 24, the value is 45.15. It has increased from 41.00 (Mar 23) to 45.15, marking an increase of 4.15.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.18. This value exceeds the healthy maximum of 3. It has decreased from 25.24 (Mar 23) to 3.18, marking a decrease of 22.06.
• For EV / EBITDA (X), as of Mar 24, the value is 69.63. This value exceeds the healthy maximum of 15. It has increased from -0.77 (Mar 23) to 69.63, marking an increase of 70.40.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 2.60 (Mar 23) to 0.73, marking a decrease of 1.87.
• For Price / BV (X), as of Mar 24, the value is -0.61. This value is below the healthy minimum of 1. It has decreased from -0.08 (Mar 23) to -0.61, marking a decrease of 0.53.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 2.61 (Mar 23) to 0.73, marking a decrease of 1.88.
• For EarningsYield, as of Mar 24, the value is 3.31. This value is below the healthy minimum of 5. It has increased from -12.52 (Mar 23) to 3.31, marking an increase of 15.83.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness